ReviewFrontiers in oncology2022

Receptor tyrosine kinase (RTK) targeting in pediatric high-grade glioma and diffuse midline glioma: Pre-clinical models and precision medicine.

Kallen Schwark et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.